Featured Research

from universities, journals, and other organizations

Study Suggests That Potential Alzheimer Drugs Might Be Dangerous

Date:
June 20, 2001
Source:
Washington University School Of Medicine
Summary:
Scientists have discovered that gamma-secretase inhibitors, the most promising drugs under development for Alzheimer’s disease, also prevent certain immune cells from being produced. These drugs are in the early stages of human testing.

St. Louis, June 19, 2001 – Scientists have discovered that gamma-secretase inhibitors, the most promising drugs under development for Alzheimer’s disease, also prevent certain immune cells from being produced. These drugs are in the early stages of human testing.

Related Articles


"Our paper suggests that these drugs could have significant side effects," says Raphael Kopan, Ph.D. "By using basic scientific methods such as the one we have developed, we hope to improve the ability of the scientific community to evaluate any Alzheimer drugs for their potential to cause life-threatening complications. Our system would also help identify drug dosages that might be safe in clinical trials." Kopan is associate professor of medicine and of molecular biology and pharmacology at Washington University School of Medicine in St. Louis.

Kopan led the study, which is described in the June 19 issue of Proceedings of the National Academy of Sciences. The first author was Brandon K. Hadland, an M.D./Ph.D. student at the School of Medicine. The St. Louis researchers collaborated with scientists at the Medical College of Georgia, the University of Tennessee and Harvard Medical School and Brigham and Women’s Hospital.

Alzheimer’s disease affects an estimated 4 million people in the United States. Researchers recently identified three genes that, when faulty, predispose individuals to this devastating neurological disorder. Two of them, presenilin-1 and presenilin-2, code for parts of a protein complex called gamma-secretase. In Alzheimer’s disease, this complex generates a protein fragment that accumulates as plaque in the brain. Using drugs, scientists hope to interfere with gamma-secretase production, thereby preventing plaque buildup.

Other parts of the body need gamma-secretase, however. Kopan and colleagues previously found that the complex is required for Notch, a receptor protein, to signal. Notch is needed for production of many cell types in our body, including blood cells such as T-cells–immune cells made and housed in blood.

The researchers feared that administering a drug that interferes with gamma-secretase production also would alter Notch function, hampering cell production in various tissues. As a model, the researchers focused on the immune system. They therefore determined the effects of a gamma-secretase inhibitor called compound #11 on cells from fetal mouse thymus, the organ where T cells develop. To simulate the continual drug therapy that would be required in humans, they treated cultured thymus lobes with a small dose of inhibitor every 12 hours.

After three days, the treated lobes had produced significantly fewer T cells than untreated ones. These results mimic previous observations of thymus cells lacking the appropriate Notch protein. The researchers therefore concluded that inhibiting gamma-secretase prevents T cells from maturing properly.

To see whether compound #11 affects later stages of T cell development, the researchers exposed thymus cells to the inhibitor on days three through six of culture. They found significantly low levels of one type of T cell, CD8, and normal quantities of a second type, CD4. They concluded that gamma-secretase also influences development at the stage when T cells differentiate into subtypes.

"We don’t want to scare the public about these exciting therapeutic advances," says Kopan. "Quite the contrary–we’re offering a way to evaluate potential Alzheimer drugs for toxicity before human testing. Doses that reduce gamma-secretase activity without eliminating it might be the safest."

###

Reference: Hadland BK, Manley NR, Su D, Longmore GD, Moore CL, Wolfe MS, Schroeter EH, Kopan R. g -Secretase inhibitors repress thymocyte development. Proceedings of the National Academy of Sciences, 13, June 19, 2001.

Funding from the National Institutes of Health, the Medical Scientist Training Program and the Alzheimer’s Association supported this research.

The full-time and volunteer faculty of Washington University School of Medicine are the physicians of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Study Suggests That Potential Alzheimer Drugs Might Be Dangerous." ScienceDaily. ScienceDaily, 20 June 2001. <www.sciencedaily.com/releases/2001/06/010620074311.htm>.
Washington University School Of Medicine. (2001, June 20). Study Suggests That Potential Alzheimer Drugs Might Be Dangerous. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2001/06/010620074311.htm
Washington University School Of Medicine. "Study Suggests That Potential Alzheimer Drugs Might Be Dangerous." ScienceDaily. www.sciencedaily.com/releases/2001/06/010620074311.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
Dads-To-Be Also Experience Hormone Changes During Pregnancy

Dads-To-Be Also Experience Hormone Changes During Pregnancy

Newsy (Dec. 18, 2014) A study from University of Michigan researchers found that expectant fathers see a decrease in testosterone as the baby's birth draws near. Video provided by Newsy
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins